Results 21 to 30 of about 19,208 (277)

Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy

open access: yesAntimicrobial Agents and Chemotherapy, 2023
Candida (Clavispora) lusitaniae is a rare, emerging non-albicans Candida species that can cause life-threatening invasive infections, spread within hospital settings, and rapidly acquire antifungal drug resistance, including multidrug resistance.
N. E. Scott   +3 more
semanticscholar   +1 more source

Improving the production of the micafungin precursor FR901379 in an industrial production strain

open access: yesMicrobial Cell Factories, 2023
Background Micafungin is an echinocandin-type antifungal agent used for the clinical treatment of invasive fungal infections. It is semisynthesized from the sulfonated lipohexapeptide FR901379, a nonribosomal peptide produced by the filamentous fungus ...
P. Men   +6 more
semanticscholar   +1 more source

A genome-wide screening of potential target genes to enhance the antifungal activity of micafungin in Schizosaccharomyces pombe. [PDF]

open access: yesPLoS ONE, 2013
Micafungin is a non-reversible inhibitor of 1, 3-β-D-glucan synthase and interferes with fungal cell wall synthesis. Clinically, micafungin has been shown to be efficacious for the treatment of invasive candidiasis and invasive aspergillosis.
Xin Zhou   +6 more
doaj   +1 more source

Effect of antifungal stewardship on micafungin prescribing practices in intensive care units at a tertiary-care hospital

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: Fungal diseases are associated with substantial global mortality and economic burden, especially in critically ill or immunocompromised patients.
Radhika Arya   +3 more
doaj   +1 more source

Serine/Threonine Phosphatase Calcineurin Orchestrates the Intrinsic Resistance to Micafungin in the Human-Pathogenic Fungus Mucor circinelloides

open access: yesAntimicrobial Agents and Chemotherapy, 2023
Procedures such as solid-organ transplants and cancer treatments can leave many patients in an immunocompromised state. This leads to their increased susceptibility to opportunistic diseases such as fungal infections.
Alexis García, E. Huh, Soo Chan Lee
semanticscholar   +1 more source

Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report

open access: yesMedical Mycology Case Reports, 2020
We report a rare case of C. krusei knee arthritis treated with instillation of micafungin and arthroscopy. A 49-year-old man hospitalized for treatment of Acute Myeloid Leukemia developed knee arthritis with C. krusei.
Jeroen C. van Egmond   +3 more
doaj   +1 more source

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

open access: yesMicroorganisms, 2021
Candida auris is an emerging and frequently multidrug-resistant pathogen against which the echinocandins are the preferred therapeutic option. We compared killing activities of anidulafungin, caspofungin, micafungin, and rezafungin against 13 isolates ...
R. Kovács   +7 more
semanticscholar   +1 more source

Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: An echinocandin, such as micafungin, is recommended as first-line treatment for invasive Candida infections in immunocompromised patients. This multicenter, observational, prospective, non- interventional study evaluated the real-world use
Samo Zver   +8 more
doaj   +1 more source

High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study

open access: yesAntimicrobial Agents and Chemotherapy, 2021
Limited data are available on the most appropriate dosing, efficacy, and safety of micafungin in neonates with invasive candidiasis (IC). This study evaluated plasma levels, efficacy, and safety of micafungin at a dose of 8 mg/kg daily for a mean of 13.3
C. Auriti   +8 more
semanticscholar   +1 more source

Micafungin-Induced Cell Wall Damage Stimulates Morphological Changes Consistent with Microcycle Conidiation in Aspergillus nidulans

open access: yesJournal of Fungi, 2021
Fungal cell wall receptors relay messages about the state of the cell wall to the nucleus through the Cell Wall Integrity Signaling (CWIS) pathway. The ultimate role of the CWIS pathway is to coordinate repair of cell wall damage and to restore normal ...
Samantha Reese   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy